OSIRIS THERAPEUTICS OSIR (NASDAQ)

$ 13.99
16:10
Change: +0.43 (+3.17%)
Volume: 122,300

Avg. Volume: 82145
P/E Ratio: NE
EPS (Annual): -1.96
Profit Margin:
Dividend & Yield(Annual): .0%
Shares Outstanding: 31,766
Institutional Shareholders: 8.9%
Last: 13.99
Change: +0.43 (+3.17%)
Prev. Close: 13.56
Open: 13.58
Day's Range: 13.57 - 14.15
52wk Range: 9.98 - 15.60
Market Value: 408,192
Beta: 1.47
12-month EPS Change: NE
Total Return Last 12 Months: -4.9%
Total Return Last 3 Years: NC%
Total Return Last 5 Years: NC%
5-Year Revenue Growth Rate: NC
5-Year Dividend Growth Rate: NC
5-Year EPS Growth Rate: NC


Headlines on OSIR
Alert me Subscribe

Geron shares recover after drop on study delay

(NEW YORK)Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration's decision to place a clinical hold ...READ MORE
May 15, 2008 5:55PM
Keywords: GERN, STEM, OSIR, GENZ, MRK, CYTX

Sector Snap: Bone graft substitutes

(NEW YORK)Increasing excitement from surgeons about new bone graft substitute products will propel that market to $1.9 billion in 2012, according to a new report.READ MORE
May 14, 2008 10:40AM
Keywords: NUVA, OSIR, MDT

Orisis sells Osteocel to NuVasive

Osiris Therapeutics Inc. announced today it entered in a deal with NuVasive Inc. to sell its business Osteocel for up to $85 million in upfront and milestone payments.READ MORE
May 09, 2008 2:45AM
Keywords: OSIR, NUVA

Osiris Stock Up on Heart Drug Study Data

(COLUMBIA, Md.)Biotechnology drug developer Osiris Therapeutics Inc. said Tuesday the Food and Drug Administration cleared the company to launch a midstage trial of Prochymal after a study showed...READ MORE
Feb 26, 2008 1:22PM
Keywords: OSIR

Intel, Finish Line Among Big Movers

(NEW YORK)Stocks that were moving substantially or trading heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSEREAD MORE
Jan 04, 2008 12:55PM
Keywords: RF, GPN, INTC, BBBY, FINL, GCO, OSIR, ACAT, SONC

Sector Snap: Biotech Attractive in 2008

(NEW YORK)Lazard Capital Markets said Wednesday rising demand for new medical treatments will continue to drive earnings growth in the biotechnology sector in 2008, providing attractive oppo...READ MORE
Jan 02, 2008 2:30PM
Keywords: AMGN, DNA, CELG, GILD, ACOR, PDLI, BIIB, OSIR, VRTX, IMGN

Intel, Finish Line Among Big Movers

(NEW YORK)Stocks that were moving substantially or trading heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSEREAD MORE
Jan 04, 2008 12:55PM
Keywords: RF, GPN, INTC, BBBY, FINL, GCO, OSIR, ACAT, SONC
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN -1.00 50.84
GILEAD SCIENCES +28.30 51.09
THIRD WAVE TECH +64.50 11.19
CELGENE CP +19.70 67.37
INVITROGEN CORP -5.70 38.41